INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2011

Antibodies against Mycobacterium avium paratuberculosis were linked to cross-reactivity with the beta-cell antigen ZnT8 in Sardinian type 1 diabetes patients.

Researchers analyzed antibody responses against the Mycobacterium avium subspecies paratuberculosis (MAP) protein MAP3865c and its cross-reactivity with the beta-cell protein ZnT8 in Sardinian T1D, T2D, and healthy subjects using an enzymatic immunoassay. Antibodies against MAP3865c recognized two immunodominant transmembrane epitopes in 52-65% of T1D patients, compared with 5-7% of T2D patients and 3-5% of healthy controls. Titers of anti-MAP3865c and anti-ZnT8 antibodies targeting these homologous epitopes correlated linearly, and pre-incubation with ZnT8 epitope peptides blocked binding to MAP3865c peptides.

Shows an association, not proof of cause and effect.

Study type
Case-control study
Who was studied
Sardinian patients with type 1 diabetes (T1D), type 2 diabetes (T2D), and healthy controls
What was measured
Antibody responses and cross-reactivity against MAP3865c and ZnT8 epitopes

THE PAPER

Antibodies recognizing Mycobacterium avium paratuberculosis epitopes cross-react with the beta-cell antigen ZnT8 in Sardinian type 1 diabetic patients.

Masala S, Paccagnini D, Cossu D, Brezar V, Pacifico A, Ahmed N, Mallone R, Sechi LA. PLoS One, 2011.

PubMed 22046415 ↗DOI 10.1371/journal.pone.0026931 ↗

Diabetes & blood sugarFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.